resized_IMG_4550 - Copy.jpg
Axios About Us Banner 16July2018.jpg
Group 4 Copy.png
Picture1.jpg
resized_IMG_4550 - Copy.jpg

Our Approach


ABOUT USAs access pioneers, our best practices are founded
on 20 years of specialized access experience.

Read our Access Best Practices

SCROLL DOWN

Our Approach


ABOUT USAs access pioneers, our best practices are founded
on 20 years of specialized access experience.

Read our Access Best Practices

Axios was formed by a group of health experts who shared the vision of an organization that could work effectively with patients, and private and public sector stakeholders to improve access to healthcare in developing countries and emerging markets.

In 1997, following the pioneering efforts of its founders in launching one of the first antiretroviral (ARV) access programs as part of the UNAIDS Drug Access Initiative – which proved that ARTs could be delivered safely and effectively in low-income settings and paved the way for subsequent price reductions – Axios International was created, followed by the Axios Foundation in 2000. Today, Axios continues to break new ground in the design and implementation of market access solutions across Africa, Asia, Latin America, Middle East and Europe. 

Our Approach

Decision Spectrum.png

Growing demand combined with ever increasing costs for healthcare are requiring a radical re-think of top-down models of state-provided healthcare to ensure sustainability.  As demand on government budgets increase, the responsibility for treatment and other medical costs is increasingly falling on the patient.

As a result, patients are taking a more active role in treatment decisions – particularly decisions to pursue, pay for and stay on treatment.

Axios’ experience has taught us that these patient decisions are guided by a complex set of considerations (see graphic). Unlike the typically displayed treatment journey, these decisions are not sequential. Instead, they are often made in parallel and are guided by the availability and accessibility of treatment at the core.

For that reason, effective market access strategies must be designed not only around payers and prescribers, but around how patients make treatment decisions – it is what we call Patient Access 360. The Patient Access 360 framework captures patient reality to aid in the design and implementation of practical solutions that solve real-world problems and resonate with patients and stakeholders alike.

The framework is used across all Axios’ strategies and programs to ensure that solutions are both medically beneficial and commercially sustainable. 

Axios About Us Banner 16July2018.jpg

Our Leadership Team


Our Leadership Team


Our Leadership 

Axios leaders are thought leaders and experts in healthcare policy and management, creative access strategies, hospital and clinical management, drug logistics, social and epidemiological research and communications.

Joseph Saba
Chief Executive Officer

Cliona Brady
Senior Director, Business Services

Roshel Jayasundera
Director, Global Consulting

Anas Nofal
Director, MENA

Peter Ahern
Executive Vice President, AI Inc.

Sowedi Muyingo
Non-Executive Board Member

Group 4 Copy.png

Our Clients and Partners


We have worked with
80% of the top 20 pharmaceutical
companies in the world

– several for more than 10 years

Our Clients and Partners


We have worked with
80% of the top 20 pharmaceutical
companies in the world

– several for more than 10 years

Our Clients and Partners

Our clients and partners are private healthcare companies, governments, international funding agencies, universities and foundations addressing some of today’s most pressing health challenges. Our robust and enduring client experience has prepared us to handle a wide range of products, markets and scenarios, and is a testament to the quality of our work. Some of our clients and partners include: 

Picture1.jpg

Our Expert Council


The future looks bright.

Together, we are building the next generation
of healthcare access

- one built for and around patients.

Our Expert Council


The future looks bright.

Together, we are building the next generation
of healthcare access

- one built for and around patients.

Our Expert Council  

The Axios International Expert Council is an independent, multi-disciplinary group passionate about building stronger patient access and adherence solutions around the world - with a particular focus on the use of technology as a facilitator for better patient outcomes. Composed of leading researchers, former and current healthcare policy makers, digital health entrepreneurs, physicians, and patient advocates, the group provides counsel to inform the next generation of patient access and adherence solutions.

Jayasree Iyer
Executive Director, Access to Medicine Foundation

HE Salem Bin Lahej
Director, Healthcare Fund Office, Dubai Health Authority (DHA)

Leah Sparks
Chief Executive Officer and Founder, Wildflower Health

Herb Riband
Fellow, Stanford University

Dr. Mohamed Ibrahim Wahid Clinical Oncologist

Dr. Sharon Tan
Senior Lecturer, Dept. of Information Systems and Analytics, National University of Singapore (NUS)

Kaakpema “KP” Yelpaala
Founder and Chief Executive Officer, access.mobile

Dr. Mohammed Omair
Consultant Rheumatologist; Assistant Professor, King Saud University